Clearside Biomedical Inc. (CLSD)
NASDAQ: CLSD
· Real-Time Price · USD
0.50
-0.04 (-7.20%)
At close: Jul 25, 2025, 3:59 PM
Clearside Biomedical Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 13.63M | 20.02M | 13.89M | 18.24M | 35.35M | 28.92M | 28.8M | 35.01M | 41.42M | 48.26M | 53.38M | 29.03M | 34.37M | 30.44M | 25.22M | 26.41M | 26.15M |
Short-Term Investments | n/a | n/a | 9.7M | 11.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30K | n/a | 160K | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 30K | 30K | 30K | 30K | 30K | 30K | 30K | 30K | 30K | 1.14M | 160K | n/a | 160K | 160K | 160K | 160K | 260K |
Receivables | 1.54M | 507K | 788K | n/a | n/a | 170K | 882K | 255K | n/a | n/a | 123K | 123K | n/a | 10M | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | 1.12M | 542K | n/a | n/a | 1.05M | 439K | n/a | 921K | n/a | n/a | n/a |
Other Current Assets | 798K | 13K | 13K | 44K | 193K | 311K | 14K | 305K | 386K | 439K | 311K | 394K | 339K | 779K | 119K | 880K | 142K |
Total Current Assets | 15.96M | 21.27M | 25.11M | 29.77M | 36.12M | 30.12M | 30.82M | 36.11M | 42.57M | 48.26M | 54.86M | 29.99M | 35.27M | 42.14M | 26.52M | 27.65M | 26.7M |
Property-Plant & Equipment | 3.67M | 3.82M | 4.02M | 4.14M | 4M | 3.87M | 3.58M | 3.05M | 2.1M | 1.87M | 663K | 597K | 625K | 607K | 695K | 779K | 862K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 3.7M | 3.85M | 4.05M | 4.17M | 4.03M | 3.9M | 3.6M | 3.08M | 2.13M | 3.04M | 823K | 757K | 785K | 767K | 855K | 939K | 1.12M |
Total Assets | 19.67M | 25.13M | 29.16M | 33.93M | 40.14M | 34.02M | 34.42M | 39.19M | 44.7M | 51.3M | 55.69M | 30.75M | 36.06M | 42.9M | 27.38M | 28.59M | 27.82M |
Account Payables | 1.91M | 1.45M | 2.36M | 1.58M | 1.36M | 2.21M | 1.87M | 1.89M | 1.59M | 1.05M | 1.74M | 2.64M | 1.4M | 941K | 776K | 1.22M | 2.34M |
Deferred Revenue | n/a | n/a | n/a | 225K | 150K | 75K | n/a | 355K | 280K | 205K | 113K | n/a | 198K | n/a | 5M | 5M | 5M |
Short-Term Debt | 378K | 375K | 373K | 370K | n/a | 364K | 362K | 359K | n/a | n/a | 407K | 395K | 391K | n/a | 384K | 380K | 377K |
Other Current Liabilities | 2.72M | 2.16M | 1.39M | 2.3M | 3.48M | 1.94M | 1.94M | 1.34M | 571K | 2.34M | 1.29M | 1.05M | 1.26M | n/a | 1.47M | 979K | 1.71M |
Total Current Liabilities | 5.01M | 4.79M | 5.59M | 5.87M | 5.95M | 6.81M | 5.83M | 5.27M | 4.98M | 5.78M | 5.2M | 5.39M | 4.16M | 4.64M | 9.16M | 8.8M | 10.3M |
Long-Term Debt | 241K | 51.77M | 49.19M | 46.73M | 44.39M | 41.99M | n/a | n/a | n/a | n/a | 31.93M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 60.33M | 58.86M | 57.95M | 9.12M | 11.04M | 480K | 40.71M | 38.09M | 36.14M | 33.98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 60.57M | 59.19M | 58.36M | 56.34M | 56M | 43.12M | 41.43M | 38.88M | 37.01M | 33.98M | 31.93M | 105K | 200K | 288K | 374K | 458K | 539K |
Total Liabilities | 65.58M | 63.98M | 63.95M | 62.22M | 61.95M | 49.93M | 47.27M | 44.16M | 41.99M | 40.7M | 37.14M | 5.5M | 4.36M | 4.93M | 9.53M | 9.25M | 10.84M |
Total Debt | 619K | 703K | 785K | 47.59M | 45.33M | 43M | 1.09M | 1.16M | 1.22M | 1.28M | 407K | 500K | 591K | 675K | 758K | 838K | 916K |
Common Stock | 77K | 77K | 75K | 74K | 74K | 63K | 62K | 62K | 61K | 61K | 60K | 60K | 60K | 60K | 60K | 59K | 58K |
Retained Earnings | -363.5M | -355.27M | -347.97M | -340.28M | -332.69M | -320.92M | -316.09M | -306.82M | -297.72M | -288.44M | -278.77M | -270.95M | -263.13M | -255.49M | -274.2M | -269.31M | -263.22M |
Comprehensive Income | n/a | n/a | 5K | -1K | -0.00 | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 | n/a | n/a | n/a | n/a | -822K |
Shareholders Equity | -45.91M | -38.85M | -34.79M | -28.29M | -21.81M | -15.91M | -12.85M | -4.97M | 2.7M | 10.61M | 18.55M | 25.25M | 31.7M | 37.98M | 17.85M | 19.34M | 16.98M |
Total Investments | n/a | n/a | 9.7M | 11.12M | n/a | n/a | n/a | n/a | n/a | 30K | n/a | 160K | n/a | n/a | n/a | n/a | n/a |